158 results
8-K
EX-10.1
ADIL
Adial Pharmaceuticals Inc
26 Apr 24
Departure of Directors or Certain Officers
4:01pm
imprisonment; conversion; and disability benefits;
d. any and all claims for violation of any federal, state, or municipal statute;
e. any and all claims
424B3
ADIL
Adial Pharmaceuticals Inc
23 Apr 24
Prospectus supplement
4:00pm
loss, advances, guarantees, pledges or other financial benefits by or through the corporation.
Certificate of Incorporation and Bylaws
Our
424B5
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Prospectus supplement for primary offering
5:31pm
stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or through the corporation.
Certificate
8-K
EX-1.1
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan … as is appropriate to reflect the relative benefits received by the Company on the one hand and by the Manager on the other from the offering of the Shares; provided
8-K
EX-99.1
6odpyah1m7dxyt
6 Mar 24
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
4:21pm
8-K
EX-10.1
qaqzhoa
6 Mar 24
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
4:21pm
424B5
6ym21s4 dej4
25 Jan 24
Prospectus supplement for primary offering
4:30pm
8-K
EX-99.1
ruk5m6
18 Jan 24
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
4:15pm
8-K
EX-99.1
201tx z2trjjyq
29 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:47pm
424B3
7co1msoe3ndq6
20 Nov 23
Prospectus supplement
7:46am
8-K
EX-99.1
x4xd5rna
14 Nov 23
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
5:29pm
8-K
EX-99.2
87glvsqcq9k6u03ff0o
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-99.1
yd9pwjalx ppd
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-10.1
tf80 5nf7
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm